Tirzepatide, a novel medication, is creating significant excitement in the healthcare community as a potential treatment for both diabetes, type 2 and body composition . This dual-action drug works by activating two separate receptors, GLP-1 and GIP, leading to better blood sugar levels and significant slimming in testing. While preliminary finding